Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores.
J Eur Acad Dermatol Venereol
; 38(4): 695-702, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38041556
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Purines
/
Pyrazoles
/
Sulfonamides
/
Azetidines
/
Dermatitis, Atopic
/
Eczema
Limits:
Adult
/
Humans
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2024
Document type:
Article
Affiliation country:
Germany
Country of publication:
United kingdom